Pfizer halted development of its new cholesterol drug following unexpected deaths during test trials. It's a huge blow to the drugmaker, which needs a blockbuster with Lipitor's patent set to expire in 5 years. Helen Palmer reports.
The lame duck Congress has decided to leave the unfinished budget for next year. Host Kai Ryssdal speaks with Congressional Quarterly's Jill Barshay about what else will — and will not — get done this week.